Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
doi:10.1084/jem.20231835
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
This effect is beneficial because it helps maintain stable blood sugar levels after meals and enhances feelings of fullness, extending satiety
This work was supported by GKLCDSM-20240101-02
This indicates that while DSIP may have a tendency to reduce infarct size, the effect was not robust enough to be considered statistically significant under the experimental conditions
The dose starts low and increases over 16 weeks to reach the maximum dose for weight loss
US$ 26.38
US$ 28.22
US$ 29.95
US$ 20.31
